Skip to content

CORIPHAR: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

CORIPHAR

BE 0437.150.690
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€25,225
2024 · €87,380-€62,155
Equity
€146,896
2024 · €146,870+€25
Cash
€62,294
2024 · €81,072-€18,779
Balance sheet total
€425,689
2024 · €533,228-€107,539

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€97,371

    down €97,371 (-35.0%), from €278,169 to €180,798

    of which Trade receivables: -€64,676

  • Cash -€18,779

    down €18,779 (-23.2%), from €81,072 to €62,294

    mainly Other debts (-€93,863) and Contributions, distributions and other (-€25,200)

  • Stocks and contracts +€8,280

    up €8,280 (+5.2%), from €159,908 to €168,188

Equity and liabilities
  • Other debts -€93,863

    down €93,863 (-78.8%), from €119,063 to €25,200

  • Debts after one year -€20,004

    down €20,004 (-23.1%), from €86,624 to €66,620

  • Trade debts +€8,669

    up €8,669 (+5.7%), from €152,122 to €160,791

Income statement
  • Gross operating margin -€23,307

    down €23,307 (-29.4%), from €79,297 to €55,990

  • Financial income -€20,846

    down €20,846 (-89.7%), from €23,238 to €2,392

  • Write-downs +€20,068

    no longer reported in 2025 (was -€20,068)

  • Financial charges -€4,041

    down €4,041 (-44.2%), from €9,149 to €5,108

  • Other operating charges +€3,212

    up €3,212 (+90.1%), from €3,566 to €6,778

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €87,380
Gross operating margin -€23,307
Staff costs -€966
Depreciation +€698
Write-downs -€20,068
Other operating charges -€3,212
Financial income -€20,846
Financial charges +€4,041
Taxes +€1,505
Result 2025 €25,225

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€27,664
Investment -€1,239
Financing -€45,204
Cash 2024 €81,072
Net result for the year +€25,225
Depreciation +€4,182
Stocks and contracts -€8,280
Receivables within one year +€97,371
Deferred charges and accrued income -€3,273
Trade debts +€8,669
Tax, wage and social debts -€2,398
Other debts -€93,863
Accrued charges and deferred income +€32
Investment in fixed assets (net) -€1,239
Debts after one year -€20,004
Contributions, distributions and other -€25,200
Cash 2025 €62,294
Every line side by side 49 lines
Line Code 2024 2025 Change %
Total assets 20/58 €533,228 €425,689 -€107,539 -20.2%
Fixed assets 21/28 €11,150 €8,207 -€2,943 -26.4%
Intangible fixed assets 21 €2,071 €1,019 -€1,052 -50.8%
Tangible fixed assets 22/27 €9,080 €7,189 -€1,891 -20.8%
Land and buildings 22 €5,162 €4,495 -€667 -12.9%
Plant, machinery and equipment 23 €2,010 €2,505 +€495 +24.6%
Furniture and vehicles 24 €1,908 €188 -€1,719 -90.1%
Current assets 29/58 €522,078 €417,482 -€104,596 -20.0%
Stocks and contracts in progress 3 €159,908 €168,188 +€8,280 +5.2%
Stocks 30/36 €159,908 €168,188 +€8,280 +5.2%
Amounts receivable within one year 40/41 €278,169 €180,798 -€97,371 -35.0%
Trade receivables 40 €143,501 €78,825 -€64,676 -45.1%
Other amounts receivable 41 €134,668 €101,973 -€32,695 -24.3%
Cash at bank and in hand 54/58 €81,072 €62,294 -€18,779 -23.2%
Deferred charges and accrued income 490/1 €2,930 €6,203 +€3,273 +111.7%
Total equity and liabilities 10/49 €533,228 €425,689 -€107,539 -20.2%
Equity 10/15 €146,870 €146,896 +€25 0.0%
Contributions 10/11 €19,000 €19,000 = 0.0%
Reserves 13 €127,290 €127,290 = 0.0%
Non-distributable reserves 130/1 €1,900 €1,900 = 0.0%
Reserves not available under the articles 1311 €1,900 €1,900 = 0.0%
Distributable reserves 133 €125,390 €125,390 = 0.0%
Profit (loss) carried forward 14 €581 €606 +€25 +4.4%
Amounts payable 17/49 €386,358 €278,794 -€107,565 -27.8%
Amounts payable after more than one year 17 €86,624 €66,620 -€20,004 -23.1%
Financial debts 170/4 €86,624 €66,620 -€20,004 -23.1%
Amounts payable within one year 42/48 €299,319 €211,726 -€87,593 -29.3%
Current portion of amounts payable after more than one year 42 €20,004 €20,004 = 0.0%
Trade debts 44 €152,122 €160,791 +€8,669 +5.7%
Suppliers 440/4 €152,122 €160,791 +€8,669 +5.7%
Taxes, remuneration and social security 45 €8,129 €5,731 -€2,398 -29.5%
Taxes 450/3 €4,809 €2,380 -€2,429 -50.5%
Remuneration and social security 454/9 €3,320 €3,350 +€31 +0.9%
Other amounts payable 47/48 €119,063 €25,200 -€93,863 -78.8%
Accrued charges and deferred income 492/3 €416 €448 +€32 +7.7%
Remuneration, social security and pensions 62 €14,513 €15,479 +€966 +6.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €4,880 €4,182 -€698 -14.3%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 -€20,068 - +€20,068
Other operating charges 640/8 €3,566 €6,778 +€3,212 +90.1%
Gross operating margin 9900 €79,297 €55,990 -€23,307 -29.4%
Operating profit (loss) 9901 €76,405 €29,552 -€46,854 -61.3%
Financial income 75/76B €23,238 €2,392 -€20,846 -89.7%
Recurring financial income 75 €23,238 €2,392 -€20,846 -89.7%
Financial charges 65/66B €9,149 €5,108 -€4,041 -44.2%
Recurring financial charges 65 €9,149 €5,108 -€4,041 -44.2%
Profit (loss) for the period before taxes 9903 €90,495 €26,836 -€63,659 -70.3%
Income taxes 67/77 €3,115 €1,610 -€1,505 -48.3%
Profit (loss) for the period 9904 €87,380 €25,225 -€62,155 -71.1%
Profit (loss) for the period to be appropriated 9905 €87,380 €25,225 -€62,155 -71.1%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.